Drugs / MSC
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT04243681 | Jul 2019 → Aug 2020 | cirrhosis of liver | Asian Institute of Gastroenterology, India | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MSC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04243681 ↗ |
| Modality | Cell therapy | “HSCs and MSCs were infused through the hepatic artery under fluoroscopic guidance.” PMID 35068788 ↗ Apr 2021 |
| Route | Other | “HSCs and MSCs were infused through the hepatic artery under fluoroscopic guidance.” PMID 35068788 ↗ Apr 2021 |